カテゴリー： QYResearch, 世界

世界の脈絡膜血管新生薬市場

◆英語タイトル：Global Choroidal Neovascularization Drug Market Professional Survey Report 2019
◆商品コード：DATA909X05451
◆発行会社（リサーチ会社）：QYResearch
◆発行日：2019年11月15日（※2024年版があります。お問い合わせください）
◆ページ数：111
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後3営業日）
◆調査対象地域：グローバル
◆産業分野：医薬品・ヘルスケア
◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,500 ⇒換算￥518,000	見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）	USD5,250 ⇒換算￥777,000	見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）	USD7,000 ⇒換算￥1,036,000	見積依頼/購入/質問フォーム

★QYResearchに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

※本調査レポートは、脈絡膜血管新生薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、AVMOC-001、BB-3、BBT-007、DG-3、エントリモド、EWA-001、その他に、用途別には、クリニック、病院、その他にセグメント区分し、脈絡膜血管新生薬の世界市場を分析しました。

・エグゼクティブ・サマリー
・脈絡膜血管新生薬の世界市場概要
・脈絡膜血管新生薬の製造コスト構成分析
・脈絡膜血管新生薬の開発・製造工場分析
・主要メーカーの主な指標（生産能力、売上、価格分析）
・脈絡膜血管新生薬の地域別分析（生産、売上、主要メーカー、輸出・輸入）
（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）
・脈絡膜血管新生薬のセグメント分析（種類別）
（AVMOC-001、BB-3、BBT-007、DG-3、エントリモド、EWA-001、その他）
・脈絡膜血管新生薬のセグメント分析（用途別）
（クリニック、病院、その他）
・脈絡膜血管新生薬の主要メーカー別分析（生産拠点、製品概要、生産・売上実績）
（Cellphire, Inc.、Chrysalis BioTherapeutics, Inc.、Cleveland BioLabs, Inc.、Cumberland Pharmaceuticals, Inc.、Diffusion Pharmaceuticals Inc.、Eli Lilly and Company、GNI Group Ltd.、Humanetics Corporation、INSYS Therapeutics, Inc.、Meabco A/S、Neumedicines Inc.、Onconova Therapeutics, Inc.、PharmaIN Corporation、Pluristem Therapeutics Inc.、ProCertus BioPharm Inc.、RDD Pharma Ltd.、RedHill Biopharma Ltd.、RxBio, Inc.、Soligenix, Inc.、）
・脈絡膜血管新生薬の市場規模予測（2019年～2025年）
（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）
・マーケティングチャネル・流通業者・顧客
・市場ダイナミクス（市場動向、機会、成長要因、課題、影響因子）
...

【レポートの概要】

The global Choroidal Neovascularization Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report focuses on Choroidal Neovascularization Drug volume and value at global level, regional level and company level. From a global perspective, this report represents overall Choroidal Neovascularization Drug market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Choroidal Neovascularization Drug in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Choroidal Neovascularization Drug manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Cellphire, Inc.
Chrysalis BioTherapeutics, Inc.
Cleveland BioLabs, Inc.
Cumberland Pharmaceuticals, Inc.
Diffusion Pharmaceuticals Inc.
Eli Lilly and Company
GNI Group Ltd.
Humanetics Corporation
INSYS Therapeutics, Inc.
Meabco A/S
Neumedicines Inc.
Onconova Therapeutics, Inc.
PharmaIN Corporation
Pluristem Therapeutics Inc.
ProCertus BioPharm Inc.
RDD Pharma Ltd.
RedHill Biopharma Ltd.
RxBio, Inc.
Soligenix, Inc.

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
AVMOC-001
BB-3
BBT-007
DG-3
Entolimod
EWA-001
Others

Segment by Application
Clinic
Hospital
Others

【レポートの目次】

Table of Contents

Executive Summary
1 Industry Overview of Choroidal Neovascularization Drug
1.1 Definition of Choroidal Neovascularization Drug
1.2 Choroidal Neovascularization Drug Segment by Type
1.2.1 Global Choroidal Neovascularization Drug Production Growth Rate Comparison by Types (2014-2025)
1.2.2 AVMOC-001
1.2.3 BB-3
1.2.4 BBT-007
1.2.5 DG-3
1.2.6 Entolimod
1.2.7 EWA-001
1.2.8 Others
1.3 Choroidal Neovascularization Drug Segment by Applications
1.3.1 Global Choroidal Neovascularization Drug Consumption Comparison by Applications (2014-2025)
1.3.2 Clinic
1.3.3 Hospital
1.3.4 Others
1.4 Global Choroidal Neovascularization Drug Overall Market
1.4.1 Global Choroidal Neovascularization Drug Revenue (2014-2025)
1.4.2 Global Choroidal Neovascularization Drug Production (2014-2025)
1.4.3 North America Choroidal Neovascularization Drug Status and Prospect (2014-2025)
1.4.4 Europe Choroidal Neovascularization Drug Status and Prospect (2014-2025)
1.4.5 China Choroidal Neovascularization Drug Status and Prospect (2014-2025)
1.4.6 Japan Choroidal Neovascularization Drug Status and Prospect (2014-2025)
1.4.7 Southeast Asia Choroidal Neovascularization Drug Status and Prospect (2014-2025)
1.4.8 India Choroidal Neovascularization Drug Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Choroidal Neovascularization Drug
2.3 Manufacturing Process Analysis of Choroidal Neovascularization Drug
2.4 Industry Chain Structure of Choroidal Neovascularization Drug

3 Development and Manufacturing Plants Analysis of Choroidal Neovascularization Drug
3.1 Capacity and Commercial Production Date
3.2 Global Choroidal Neovascularization Drug Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of Choroidal Neovascularization Drug
3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers
4.1 Choroidal Neovascularization Drug Production and Capacity Analysis
4.2 Choroidal Neovascularization Drug Revenue Analysis
4.3 Choroidal Neovascularization Drug Price Analysis
4.4 Market Concentration Degree

5 Choroidal Neovascularization Drug Regional Market Analysis
5.1 Choroidal Neovascularization Drug Production by Regions
5.1.1 Global Choroidal Neovascularization Drug Production by Regions
5.1.2 Global Choroidal Neovascularization Drug Revenue by Regions
5.2 Choroidal Neovascularization Drug Consumption by Regions
5.3 North America Choroidal Neovascularization Drug Market Analysis
5.3.1 North America Choroidal Neovascularization Drug Production
5.3.2 North America Choroidal Neovascularization Drug Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America Choroidal Neovascularization Drug Import and Export
5.4 Europe Choroidal Neovascularization Drug Market Analysis
5.4.1 Europe Choroidal Neovascularization Drug Production
5.4.2 Europe Choroidal Neovascularization Drug Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe Choroidal Neovascularization Drug Import and Export
5.5 China Choroidal Neovascularization Drug Market Analysis
5.5.1 China Choroidal Neovascularization Drug Production
5.5.2 China Choroidal Neovascularization Drug Revenue
5.5.3 Key Manufacturers in China
5.5.4 China Choroidal Neovascularization Drug Import and Export
5.6 Japan Choroidal Neovascularization Drug Market Analysis
5.6.1 Japan Choroidal Neovascularization Drug Production
5.6.2 Japan Choroidal Neovascularization Drug Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan Choroidal Neovascularization Drug Import and Export
5.7 Southeast Asia Choroidal Neovascularization Drug Market Analysis
5.7.1 Southeast Asia Choroidal Neovascularization Drug Production
5.7.2 Southeast Asia Choroidal Neovascularization Drug Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia Choroidal Neovascularization Drug Import and Export
5.8 India Choroidal Neovascularization Drug Market Analysis
5.8.1 India Choroidal Neovascularization Drug Production
5.8.2 India Choroidal Neovascularization Drug Revenue
5.8.3 Key Manufacturers in India
5.8.4 India Choroidal Neovascularization Drug Import and Export

6 Choroidal Neovascularization Drug Segment Market Analysis (by Type)
6.1 Global Choroidal Neovascularization Drug Production by Type
6.2 Global Choroidal Neovascularization Drug Revenue by Type
6.3 Choroidal Neovascularization Drug Price by Type

7 Choroidal Neovascularization Drug Segment Market Analysis (by Application)
7.1 Global Choroidal Neovascularization Drug Consumption by Application
7.2 Global Choroidal Neovascularization Drug Consumption Market Share by Application (2014-2019)

8 Choroidal Neovascularization Drug Major Manufacturers Analysis
8.1 Cellphire, Inc.
8.1.1 Cellphire, Inc. Choroidal Neovascularization Drug Production Sites and Area Served
8.1.2 Cellphire, Inc. Product Introduction, Application and Specification
8.1.3 Cellphire, Inc. Choroidal Neovascularization Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.1.4 Main Business and Markets Served
8.2 Chrysalis BioTherapeutics, Inc.
8.2.1 Chrysalis BioTherapeutics, Inc. Choroidal Neovascularization Drug Production Sites and Area Served
8.2.2 Chrysalis BioTherapeutics, Inc. Product Introduction, Application and Specification
8.2.3 Chrysalis BioTherapeutics, Inc. Choroidal Neovascularization Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.2.4 Main Business and Markets Served
8.3 Cleveland BioLabs, Inc.
8.3.1 Cleveland BioLabs, Inc. Choroidal Neovascularization Drug Production Sites and Area Served
8.3.2 Cleveland BioLabs, Inc. Product Introduction, Application and Specification
8.3.3 Cleveland BioLabs, Inc. Choroidal Neovascularization Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.3.4 Main Business and Markets Served
8.4 Cumberland Pharmaceuticals, Inc.
8.4.1 Cumberland Pharmaceuticals, Inc. Choroidal Neovascularization Drug Production Sites and Area Served
8.4.2 Cumberland Pharmaceuticals, Inc. Product Introduction, Application and Specification
8.4.3 Cumberland Pharmaceuticals, Inc. Choroidal Neovascularization Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.4.4 Main Business and Markets Served
8.5 Diffusion Pharmaceuticals Inc.
8.5.1 Diffusion Pharmaceuticals Inc. Choroidal Neovascularization Drug Production Sites and Area Served
8.5.2 Diffusion Pharmaceuticals Inc. Product Introduction, Application and Specification
8.5.3 Diffusion Pharmaceuticals Inc. Choroidal Neovascularization Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.5.4 Main Business and Markets Served
8.6 Eli Lilly and Company
8.6.1 Eli Lilly and Company Choroidal Neovascularization Drug Production Sites and Area Served
8.6.2 Eli Lilly and Company Product Introduction, Application and Specification
8.6.3 Eli Lilly and Company Choroidal Neovascularization Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.6.4 Main Business and Markets Served
8.7 GNI Group Ltd.
8.7.1 GNI Group Ltd. Choroidal Neovascularization Drug Production Sites and Area Served
8.7.2 GNI Group Ltd. Product Introduction, Application and Specification
8.7.3 GNI Group Ltd. Choroidal Neovascularization Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.7.4 Main Business and Markets Served
8.8 Humanetics Corporation
8.8.1 Humanetics Corporation Choroidal Neovascularization Drug Production Sites and Area Served
8.8.2 Humanetics Corporation Product Introduction, Application and Specification
8.8.3 Humanetics Corporation Choroidal Neovascularization Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.8.4 Main Business and Markets Served
8.9 INSYS Therapeutics, Inc.
8.9.1 INSYS Therapeutics, Inc. Choroidal Neovascularization Drug Production Sites and Area Served
8.9.2 INSYS Therapeutics, Inc. Product Introduction, Application and Specification
8.9.3 INSYS Therapeutics, Inc. Choroidal Neovascularization Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.9.4 Main Business and Markets Served
8.10 Meabco A/S
8.10.1 Meabco A/S Choroidal Neovascularization Drug Production Sites and Area Served
8.10.2 Meabco A/S Product Introduction, Application and Specification
8.10.3 Meabco A/S Choroidal Neovascularization Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.10.4 Main Business and Markets Served
8.11 Neumedicines Inc.
8.12 Onconova Therapeutics, Inc.
8.13 PharmaIN Corporation
8.14 Pluristem Therapeutics Inc.
8.15 ProCertus BioPharm Inc.
8.16 RDD Pharma Ltd.
8.17 RedHill Biopharma Ltd.
8.18 RxBio, Inc.
8.19 Soligenix, Inc.

9 Development Trend of Analysis of Choroidal Neovascularization Drug Market
9.1 Global Choroidal Neovascularization Drug Market Trend Analysis
9.1.1 Global Choroidal Neovascularization Drug Market Size (Volume and Value) Forecast 2019-2025
9.2 Choroidal Neovascularization Drug Regional Market Trend
9.2.1 North America Choroidal Neovascularization Drug Forecast 2019-2025
9.2.2 Europe Choroidal Neovascularization Drug Forecast 2019-2025
9.2.3 China Choroidal Neovascularization Drug Forecast 2019-2025
9.2.4 Japan Choroidal Neovascularization Drug Forecast 2019-2025
9.2.5 Southeast Asia Choroidal Neovascularization Drug Forecast 2019-2025
9.2.6 India Choroidal Neovascularization Drug Forecast 2019-2025
9.3 Choroidal Neovascularization Drug Market Trend (Product Type)
9.4 Choroidal Neovascularization Drug Market Trend (Application)

10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.3 Choroidal Neovascularization Drug Customers

11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors

12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer

List of Tables and Figures
Figure Picture of Choroidal Neovascularization Drug
Table Global Choroidal Neovascularization Drug Production (K Pcs) Growth Rate Comparison by Types (2014-2025)
Figure Global Choroidal Neovascularization Drug Production Market Share by Types in 2018
Figure AVMOC-001 Product Picture
Figure BB-3 Product Picture
Figure BBT-007 Product Picture
Figure DG-3 Product Picture
Figure Entolimod Product Picture
Figure EWA-001 Product Picture
Figure Others Product Picture
Table Global Choroidal Neovascularization Drug Consumption (K Pcs) Comparison by Applications (2014-2025)
Figure Global Choroidal Neovascularization Drug Consumption Market Share by Applications in 2018
Figure Clinic
Figure Hospital
Figure Others
Figure Global Choroidal Neovascularization Drug Revenue (Million USD) (2014-2025)
Figure Global Choroidal Neovascularization Drug Production (K Pcs) (2014-2025)
Figure North America Choroidal Neovascularization Drug Market Size (Million USD) (2014-2025)
Figure Europe Choroidal Neovascularization Drug Market Size (Million USD) (2014-2025)
Figure China Choroidal Neovascularization Drug Market Size (Million USD) (2014-2025)
Figure Japan Choroidal Neovascularization Drug Market Size (Million USD) (2014-2025)
Figure Southeast Asia Choroidal Neovascularization Drug Market Size (Million USD) (2014-2025)
Figure India Choroidal Neovascularization Drug Market Size (Million USD) (2014-2025)
Table Choroidal Neovascularization Drug Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Choroidal Neovascularization Drug in 2018
Figure Manufacturing Process Analysis of Choroidal Neovascularization Drug
Figure Industry Chain Structure of Choroidal Neovascularization Drug
Table Capacity and Commercial Production Date of Key Manufacturers
Table Global Choroidal Neovascularization Drug Manufacturing Plants Distribution
Table Choroidal Neovascularization Drug Major Manufacturers Technology Source and Market Position
Table Recent Development and Expansion Plans in Future
Table Choroidal Neovascularization Drug Capacity (K Pcs) of Major Manufacturers (2014-2019)
Table Choroidal Neovascularization Drug Production (K Pcs) of Major Manufacturers (2014-2019)
Table Choroidal Neovascularization Drug Production Market Share of Major Manufacturers (2014-2019)
Figure Choroidal Neovascularization Drug Production Share by Manufacturers in 2018
Table Choroidal Neovascularization Drug Revenue (Million US$) of Major Manufacturers (2014-2019)
Table Choroidal Neovascularization Drug Revenue Market Share of Major Manufacturers (2014-2019)
Figure Choroidal Neovascularization Drug Revenue Share by Manufacturers in 2018
Table Choroidal Neovascularization Drug Average Price (USD/Pcs) of Major Manufacturers (2014-2019)
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Global Choroidal Neovascularization Drug Production by Regions 2014-2019 (K Pcs)
Table Global Choroidal Neovascularization Drug Production Market Share by Regions 2014-2019
Figure Global Choroidal Neovascularization Drug Production Market Share by Regions in 2018
Table Global Choroidal Neovascularization Drug Revenue by Regions 2014-2019 (Million USD)
Table Global Choroidal Neovascularization Drug Revenue Market Share by Regions 2014-2019
Figure Global Choroidal Neovascularization Drug Revenue Market Share by Regions in 2018
Table Global Choroidal Neovascularization Drug Consumption by Regions 2014-2019 (K Pcs)
Table Global Choroidal Neovascularization Drug Consumption Market Share by Regions 2014-2019
Figure North America Choroidal Neovascularization Drug Production Growth Rate 2014-2019 (K Pcs)
Figure North America Choroidal Neovascularization Drug Revenue Growth Rate 2014-2019 (Million USD)
Table North America Choroidal Neovascularization Drug Production, Consumption Import and Export (K Pcs)
Figure Europe Choroidal Neovascularization Drug Production Growth Rate 2014-2019 (K Pcs)
Figure Europe Choroidal Neovascularization Drug Revenue Growth Rate 2014-2019 (Million USD)
Table Europe Choroidal Neovascularization Drug Production, Consumption Import and Export (K Pcs)
Figure China Choroidal Neovascularization Drug Production Growth Rate 2014-2019 (K Pcs)
Figure China Choroidal Neovascularization Drug Revenue Growth Rate 2014-2019 (Million USD)
Table China Choroidal Neovascularization Drug Production, Consumption Import and Export (K Pcs)
Figure Japan Choroidal Neovascularization Drug Production Growth Rate 2014-2019 (K Pcs)
Figure Japan Choroidal Neovascularization Drug Revenue Growth Rate 2014-2019 (Million USD)
Table Japan Choroidal Neovascularization Drug Production, Consumption Import and Export (K Pcs)
Figure Southeast Asia Choroidal Neovascularization Drug Production Growth Rate 2014-2019 (K Pcs)
Figure Southeast Asia Choroidal Neovascularization Drug Revenue Growth Rate 2014-2019 (Million USD)
Table Southeast Asia Choroidal Neovascularization Drug Production, Consumption Import and Export (K Pcs)
Figure India Choroidal Neovascularization Drug Production Growth Rate 2014-2019 (K Pcs)
Figure India Choroidal Neovascularization Drug Revenue Growth Rate 2014-2019 (Million USD)
Table India Choroidal Neovascularization Drug Production, Consumption Import and Export (K Pcs)
Figure Global Consumption Choroidal Neovascularization Drug Market Share by Application (2014-2019)
Figure Global Value (Consumption) Choroidal Neovascularization Drug Market Share by Application (2014-2019)
Table Cellphire, Inc. Choroidal Neovascularization Drug Production Sites and Area Served
Table Cellphire, Inc. Choroidal Neovascularization Drug Product Introduction, Application and Specification
Table Cellphire, Inc. Choroidal Neovascularization Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Cellphire, Inc. Choroidal Neovascularization Drug Production Growth Rate (2014-2019)
Table Cellphire, Inc. Choroidal Neovascularization Drug Production Market Share (2014-2019)
Figure Cellphire, Inc. Choroidal Neovascularization Drug Revenue Market Share (2014-2019)
Table Cellphire, Inc. Choroidal Neovascularization Drug Main Business and Markets Served
Table Chrysalis BioTherapeutics, Inc. Choroidal Neovascularization Drug Production Sites and Area Served
Table Chrysalis BioTherapeutics, Inc. Choroidal Neovascularization Drug Product Introduction, Application and Specification
Table Chrysalis BioTherapeutics, Inc. Choroidal Neovascularization Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Chrysalis BioTherapeutics, Inc. Choroidal Neovascularization Drug Production Growth Rate (2014-2019)
Table Chrysalis BioTherapeutics, Inc. Choroidal Neovascularization Drug Production Market Share (2014-2019)
Figure Chrysalis BioTherapeutics, Inc. Choroidal Neovascularization Drug Revenue Market Share (2014-2019)
Table Chrysalis BioTherapeutics, Inc. Choroidal Neovascularization Drug Main Business and Markets Served
Table Cleveland BioLabs, Inc. Choroidal Neovascularization Drug Production Sites and Area Served
Table Cleveland BioLabs, Inc. Choroidal Neovascularization Drug Product Introduction, Application and Specification
Table Cleveland BioLabs, Inc. Choroidal Neovascularization Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Cleveland BioLabs, Inc. Choroidal Neovascularization Drug Production Growth Rate (2014-2019)
Table Cleveland BioLabs, Inc. Choroidal Neovascularization Drug Production Market Share (2014-2019)
Figure Cleveland BioLabs, Inc. Choroidal Neovascularization Drug Revenue Market Share (2014-2019)
Table Cleveland BioLabs, Inc. Choroidal Neovascularization Drug Main Business and Markets Served
Table Cumberland Pharmaceuticals, Inc. Choroidal Neovascularization Drug Production Sites and Area Served
Table Cumberland Pharmaceuticals, Inc. Choroidal Neovascularization Drug Product Introduction, Application and Specification
Table Cumberland Pharmaceuticals, Inc. Choroidal Neovascularization Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Cumberland Pharmaceuticals, Inc. Choroidal Neovascularization Drug Production Growth Rate (2014-2019)
Table Cumberland Pharmaceuticals, Inc. Choroidal Neovascularization Drug Production Market Share (2014-2019)
Figure Cumberland Pharmaceuticals, Inc. Choroidal Neovascularization Drug Revenue Market Share (2014-2019)
Table Cumberland Pharmaceuticals, Inc. Choroidal Neovascularization Drug Main Business and Markets Served
Table Diffusion Pharmaceuticals Inc. Choroidal Neovascularization Drug Production Sites and Area Served
Table Diffusion Pharmaceuticals Inc. Choroidal Neovascularization Drug Product Introduction, Application and Specification
Table Diffusion Pharmaceuticals Inc. Choroidal Neovascularization Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Diffusion Pharmaceuticals Inc. Choroidal Neovascularization Drug Production Growth Rate (2014-2019)
Table Diffusion Pharmaceuticals Inc. Choroidal Neovascularization Drug Production Market Share (2014-2019)
Figure Diffusion Pharmaceuticals Inc. Choroidal Neovascularization Drug Revenue Market Share (2014-2019)
Table Diffusion Pharmaceuticals Inc. Choroidal Neovascularization Drug Main Business and Markets Served
Table Eli Lilly and Company Choroidal Neovascularization Drug Production Sites and Area Served
Table Eli Lilly and Company Choroidal Neovascularization Drug Product Introduction, Application and Specification
Table Eli Lilly and Company Choroidal Neovascularization Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Eli Lilly and Company Choroidal Neovascularization Drug Production Growth Rate (2014-2019)
Table Eli Lilly and Company Choroidal Neovascularization Drug Production Market Share (2014-2019)
Figure Eli Lilly and Company Choroidal Neovascularization Drug Revenue Market Share (2014-2019)
Table Eli Lilly and Company Choroidal Neovascularization Drug Main Business and Markets Served
Table GNI Group Ltd. Choroidal Neovascularization Drug Production Sites and Area Served
Table GNI Group Ltd. Choroidal Neovascularization Drug Product Introduction, Application and Specification
Table GNI Group Ltd. Choroidal Neovascularization Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table GNI Group Ltd. Choroidal Neovascularization Drug Production Growth Rate (2014-2019)
Table GNI Group Ltd. Choroidal Neovascularization Drug Production Market Share (2014-2019)
Figure GNI Group Ltd. Choroidal Neovascularization Drug Revenue Market Share (2014-2019)
Table GNI Group Ltd. Choroidal Neovascularization Drug Main Business and Markets Served
Table Humanetics Corporation Choroidal Neovascularization Drug Production Sites and Area Served
Table Humanetics Corporation Choroidal Neovascularization Drug Product Introduction, Application and Specification
Table Humanetics Corporation Choroidal Neovascularization Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Humanetics Corporation Choroidal Neovascularization Drug Production Growth Rate (2014-2019)
Table Humanetics Corporation Choroidal Neovascularization Drug Production Market Share (2014-2019)
Figure Humanetics Corporation Choroidal Neovascularization Drug Revenue Market Share (2014-2019)
Table Humanetics Corporation Choroidal Neovascularization Drug Main Business and Markets Served
Table INSYS Therapeutics, Inc. Choroidal Neovascularization Drug Production Sites and Area Served
Table INSYS Therapeutics, Inc. Choroidal Neovascularization Drug Product Introduction, Application and Specification
Table INSYS Therapeutics, Inc. Choroidal Neovascularization Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table INSYS Therapeutics, Inc. Choroidal Neovascularization Drug Production Growth Rate (2014-2019)
Table INSYS Therapeutics, Inc. Choroidal Neovascularization Drug Production Market Share (2014-2019)
Figure INSYS Therapeutics, Inc. Choroidal Neovascularization Drug Revenue Market Share (2014-2019)
Table INSYS Therapeutics, Inc. Choroidal Neovascularization Drug Main Business and Markets Served
Table Meabco A/S Choroidal Neovascularization Drug Production Sites and Area Served
Table Meabco A/S Choroidal Neovascularization Drug Product Introduction, Application and Specification
Table Meabco A/S Choroidal Neovascularization Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Meabco A/S Choroidal Neovascularization Drug Production Growth Rate (2014-2019)
Table Meabco A/S Choroidal Neovascularization Drug Production Market Share (2014-2019)
Figure Meabco A/S Choroidal Neovascularization Drug Revenue Market Share (2014-2019)
Table Meabco A/S Choroidal Neovascularization Drug Main Business and Markets Served
Table Neumedicines Inc. Choroidal Neovascularization Drug Production Sites and Area Served
Table Onconova Therapeutics, Inc. Choroidal Neovascularization Drug Production Sites and Area Served
Table PharmaIN Corporation Choroidal Neovascularization Drug Production Sites and Area Served
Table Pluristem Therapeutics Inc. Choroidal Neovascularization Drug Production Sites and Area Served
Table ProCertus BioPharm Inc. Choroidal Neovascularization Drug Production Sites and Area Served
Table RDD Pharma Ltd. Choroidal Neovascularization Drug Production Sites and Area Served
Table RedHill Biopharma Ltd. Choroidal Neovascularization Drug Production Sites and Area Served
Table RxBio, Inc. Choroidal Neovascularization Drug Production Sites and Area Served
Table Soligenix, Inc. Choroidal Neovascularization Drug Production Sites and Area Served
Figure Global Choroidal Neovascularization Drug Production (K Pcs) Growth Rate Forecast 2019-2025
Figure Global Choroidal Neovascularization Drug Revenue (Million USD) Growth Rate Forecast 2019-2025
Figure Global Choroidal Neovascularization Drug Sales Price (USD/Pcs) Forecast 2019-2025
Figure North America Choroidal Neovascularization Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure North America Choroidal Neovascularization Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Europe Choroidal Neovascularization Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Europe Choroidal Neovascularization Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure China Choroidal Neovascularization Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure China Choroidal Neovascularization Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Japan Choroidal Neovascularization Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Japan Choroidal Neovascularization Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Southeast Asia Choroidal Neovascularization Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Southeast Asia Choroidal Neovascularization Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure India Choroidal Neovascularization Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure India Choroidal Neovascularization Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Table Global Production (K Pcs) of Choroidal Neovascularization Drug by Type (2019-2025)
Table Global Consumption (K Pcs) of Choroidal Neovascularization Drug by Application (2019-2025)
Table Choroidal Neovascularization Drug Distributors List
Table Choroidal Neovascularization Drug Customers List
Table Market Key Trends
Table Key Opportunities
Table Market Key Drivers
Table Key Challenges
Table Key Influence Factors
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

【掲載企業】

Cellphire, Inc.、Chrysalis BioTherapeutics, Inc.、Cleveland BioLabs, Inc.、Cumberland Pharmaceuticals, Inc.、Diffusion Pharmaceuticals Inc.、Eli Lilly and Company、GNI Group Ltd.、Humanetics Corporation、INSYS Therapeutics, Inc.、Meabco A/S、Neumedicines Inc.、Onconova Therapeutics, Inc.、PharmaIN Corporation、Pluristem Therapeutics Inc.、ProCertus BioPharm Inc.、RDD Pharma Ltd.、RedHill Biopharma Ltd.、RxBio, Inc.、Soligenix, Inc.、

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界の脈絡膜血管新生薬市場(Global Choroidal Neovascularization Drug Market Professional Survey Report 2019)]についてメールでお問い合わせはこちらでお願いします。

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 GlobalResearch.jp